Further contributing to QTP susceptibility, polymorphisms in the angiotensin-converting enzyme and angiotensin II type 1 receptor genes contribute additively to QTP, which is prevalent in the majority of end-stage renal disease patients [28]. The gene discussed is ACE; the disease is chronic kidney disease.